Document Detail

Cardioprotection techniques: preconditioning, postconditioning and remote conditioning (basic science).
MedLine Citation:
PMID:  23270554     Owner:  NLM     Status:  Publisher    
Ischemic heart disease (IHD) is the leading cause of death and disability worldwide. The major pathological consequences of IHD arise from the detrimental effects of acute ischemia-reperfusion injury (IRI) on the myocardium. Therefore, in order to improve clinical outcomes in patients with IHD, novel therapeutic strategies are required to protect the myocardium from acute IRI and preserve cardiac function (cardioprotection). In this regard, endogenous cardioprotective strategies such as ischemic preconditioning (IPC), ischemic postconditioning (IPost) and remote ischemic conditioning (RIC) may provide novel approaches for protecting the heart in clinical settings in which the patient experiences acute myocardial IRI. In this review article, we provide an overview of these endogenous cardioprotective strategies with respect to the pre-clinical experimental literature, exploring their major characteristics and underlying signaling mechanisms. The application of these therapeutic strategies in the clinical setting for potential patient benefit is reviewed in another article in this special issue.
Derek J Hausenloy
Related Documents :
24806384 - Etiology and clinical implications of microvascular dysfunction in patients with acute ...
23049084 - Characteristics of aortic wall extracellular matrix in patients with acute myocardial i...
8279354 - Early and late angiotensin-converting enzyme inhibition in acute myocardial infarction.
20631034 - Magnetic resonance imaging delineates the ischemic area at risk and myocardial salvage ...
24806384 - Etiology and clinical implications of microvascular dysfunction in patients with acute ...
23291664 - Prognosis of patients with atrial fibrillation undergoing percutaneous coronary interve...
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2012-12-21
Journal Detail:
Title:  Current pharmaceutical design     Volume:  -     ISSN:  1873-4286     ISO Abbreviation:  Curr. Pharm. Des.     Publication Date:  2012 Dec 
Date Detail:
Created Date:  2012-12-28     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9602487     Medline TA:  Curr Pharm Des     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
The Hatter Cardiovascular Institute, University College London Hospital & Medical School, 67 Chenies Mews, London, WC1E 6HX, UK.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  No-reflow: Incidence and Detection in The Cath-Lab.
Next Document:  Protecting the heart: Biological targets and Clinical Strategies.